Larimar Therapeutics
LRMR
LRMR
68 hedge funds and large institutions have $174M invested in Larimar Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 4 closing their positions.
Holders
68
Holders Change
+20
Holders Change %
+41.67%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
23
Reduced
12
Closed
4
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$3K
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$3.04M |
2 |
2
Verition Fund Management
Greenwich,
Connecticut
|
$8.78M |
3 |
FAM
3
Fred Alger Management
New York
|
$1.29M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.16M |
5 |
5
Millennium Management
New York
|
$1.94M |
Top Sellers
1 |
CA
1
CHI Advisors
New York
|
$12.4M |
2 |
CC
2
Commodore Capital
New York
|
$0 |
3 |
PA
3
Perceptive Advisors
New York
|
$10.3M |
4 |
MP
4
Mangrove Partners
Greenwich,
Connecticut
|
$3.65M |
5 |
5
Morgan Stanley
New York
|
$292K |